Search

Both benefits and concerns exist, but implementing policies and regulations promotes employee productivity, guards safety. Although marijuana provides health benefits, there are many concerns when it comes to productivity and even safety in the workplace for individuals who use medical marijuana. [Extracted from the article]

Fifteen years later when the employee's claim was launched against the firm, the employer stipulated that the employee had experienced a "compensable accident" that led to a workers' compensation claim. An employee of a construction company suffered serious injuries at work and subsequently received a recommendation from his physician that he use medical marijuana. [Extracted from the article]

The article discusses the story of glaucoma patient Robert C. Randall's successful fight to get marijuana legally from the U.S. federal government to treat his disease. Randall was diagnosed by an ophthalmologist of having glaucoma in 1972. In 1975, he was charged by the government for cultivating marijuana in his apartment in Washington, D.C. He used the research of Robert Hepler about clinical trials on marijuana and glaucoma in his defense. In November 1976, Randall received his first supplies of marijuana from the government. INSET: THE PHARMACIST'S CHALLENGE.

The article discusses the different truths and myths about medical marijuana. Topics covered include how the recreational use of marijuana in small quantities is legal in Colorado and Washington. Also mentioned are the adverse effects to using medical marijuana like respiratory and cardiovascular problems and the proper administration of medical marijuana.

The article reports on the study which reveals that additional research are needed on the effectiveness of delta 9-tetrahydrocannabinol (THC) and cannabidiol (CBD), active components of marijuana, for epilepsy treatment. Topics mentioned include the insights of researcher Samba Reddy on the research for medical marijuana, the proposal to legalize medical marijuana, and the medical care for epileptic patients.

The article presents the author's views on the increased drug abuse cases in the U.S. Various topics discussed include report on marijuana legalization at the Rocky Mountain High Intensity Drug Trafficking Area website, increased use of marijuana between 2013-2014, economic aspects of legalization and drug naloxone.

The article discusses a study published in the "Journal of Pharmacology and Experimental Therapeutics" regarding the therapeutic use of medical cannabis for epilepsy. It states the major components of cannabis with antiseizure potential such as cannabidiol (CBD) and delta 9-tetrahydrocannabinol (THC). Also mentioned the approval by Food and Drug Administration (FDA) for the medical potential of marijuana.

The article discusses the opportunities and problems associated with medical marijuana or cannabis. Cannabis contains transdelta-9-tetrahydrocannabinol (THC) and cannabidiol and its derivatives. The U.S. Food and Drug Administration (FDA) has approved the use of cannabis for acute and delayed nausea and emesis caused by chemotherapy. The adverse events and counseling issues associated with cannabis use are also discussed.

The article discusses the use of medical marijuana for long-term illnesses and an emerging trend towards its legalization. It cites the states that have allowed its distribution to patients upon a physician's recommendation such as Alaska, Colorado and New Jersey as the 14th state to pass medical marijuana legislation. It indicates the reluctance of the federal government to legalize the use of medical marijuana. It points to the pharmacists who can help counteract marijuana's negative stigma.

The article focuses on two key issues that were discussed at the 2015 annual meeting of the American Pharmacists Association (APhA). The two issues are the policy that supports the participation of pharmacists in furnishing medical marijuana, and the discouragement of APhA for pharmacists to participate in executions on the basis that it is contrary to their role as providers of health care. Other observations at the meeting are also presented including the increase in the number of attendees.

Posts from the microblogging website Facebook, regarding medical cannabis, pharmacist provider status, and adherence to proton pump inhibitors, are presented.

The author presents insights on the issue of medical marijuana in the U.S. Topics discussed include the sale of the product through license pharmacies, proposal to provide the product to the public with little or no quality control and research on the impact of medical marijuana on the safety of citizens. Also mentioned are traffic statistics and seizures of marijuana in Colorado.

In the article, the author discusses the effects of the legalization of marijuana use in the medical sector. He claims that the laws in various U.S. states that legalize marijuana use are being exploited. He cites as examples the cases in California and Montana, in which marijuana are legally trafficked, resulting in the more than 1,000% increase in marijuana abuse by drivers in Montana. He suggests that marijuana should be produced to the same standards as pharmaceuticals.

An introduction to the journal is presented in which the author discusses various reports published within the issue including one on medical marijuana, one about products and strategies for treating sunburn, and one on the treatment of rosacea.

This article deals with the guidelines issued by the U.S. Attorney General (AG) for states that have authorized the use of marijuana for medical purposes.

The article announces that Michigan voters have approved a measure that will allow seriously ill patients to register to use marijuana according to their doctor's recommendation. This makes the state the first one in the Midwest to enact a modern medical marijuana law, according to the Marijuana Policy Project. The measure went into effect on December 4, 2008 and the measure was drafted by Michigan's Coalition for Compassionate Care (MCCC).